Health allocation hits Sh5.2 Trillion as government moves to cut donor dependency

The Dei BioPharma drugs and vaccines manufacturing facility in Matugga, near Kampala-Uganda.

An aerial view captures the sprawling Dei BioPharma plant in Matugga, Kampala, a testament to Uganda's growing prowess in biotechnology ...

Minister of State for Youth and Children Affairs Balaam Barugahara, flanked by Dei Group founder and lead scientist Dr. Matthias Magoola, addresses members of the press during a tour of the Dei Biopharma manufacturing facility in Matugga. The multibillion-shilling plant is expected to position Uganda as a regional pharmaceutical hub and a leader in the production of essential vaccines and biological drugs.

Ministers Musenero, Balaam hail Dei Biopharma as engine for industrial sovereignty

by JOSEPH NSIMBI | UG STANDARD REPORTER

30/04/2026

0

Science and Technology Minister Monica Musenero and State Minister for Youth and Children Affairs Balaam Barugahara, flanked by lead scientist ...

Ugandan firm Dei BioPharma, led by Dr. Matthias Magoola, secures new patent rights for innovative mRNA Ebola and Mpox vaccines. The announcement came at an Africa CDC meeting in South Africa, positioning the company as a potential Continental Contract Drug Manufacturing Organization.

Dr. Magoola unveils gene therapy breakthrough to transform sickle cell treatment

by Julian Ninsiima | Reporter

02/02/2026

0

Dr. Magoola, who is leading Dei BioPharma to develop a manufacturing facility with atleast 26 different units, says the biotech ...

Dei Biopharma founder Dr. Matthias Magoola receives the prestigious Pharma Ratna Universe Award in India for his visionary leadership and impact on African healthcare. Learn about his journey and recognition.

Dr. Magoola gets FDA boost for rare borne drug in US market

by JOSEPH NSIMBI | UG STANDARD REPORTER

08/01/2026

0

Dr. Matthias Magoola and Dei Biopharma have received a significant boost after the U.S. FDA accepted their application for a ...

Dei BioPharma’s Dr. Magoola unveils new mRNA Ebola and Mpox vaccines at Africa CDC meeting in South Africa

by MANFRED TUMUSIIME | UG STANDARD REPORTER

27/10/2025

0

Ugandan firm Dei BioPharma, led by Dr. Matthias Magoola, secures new patent rights for innovative mRNA Ebola and Mpox vaccines. ...

Dr. Arthur Kayanja has dismissed claims that he left Dei BioPharma as Fake News!

Dr. Kayanja: I have not left Dei BioPharma, its fake news!

by LILIAN MUWONGE | UG STANDARD REPORTER

01/10/2025

0

Dr. Arthur Kayanja has dismissed claims that he left Dei BioPharma as Fake News KAMPALA, UGANDA - Dei BioPharma has ...

Dr. Matthias Magoola, founder of Dei Biopharma Ltd., receives Lifetime Achievement Award in Canada for his contributions to science, health, and community

Dei Biopharma founder Dr. Magoola honored with Lifetime Achievement Award in Canada

by LILIAN MUWONGE | UG STANDARD REPORTER

08/09/2025

0

Dr. Matthias Magoola, founder of Dei Biopharma Ltd., receives Lifetime Achievement Award in Canada for his contributions to science, health, ...

Dr. Magoola, Dei BioPharma, secures US patents for universal mRNA cancer vaccine & affordable scFv immune therapy. Global treatment equity, Uganda biotech breakthrough.

Dei BioPharma receives second US FDA approval for key diabetes drug

by Ronald Mayega | Reporter

22/08/2025

0

Dei BioPharma projects $15B in annual revenue after its development plan for two novel GLP-1 drugs, liraglutide and semaglutide, is ...

TOP STORY: Dei BioPharma’s Dr. Magoola files new US patents for groundbreaking cancer and immune therapies

by LILIAN MUWONGE | UG STANDARD REPORTER

30/07/2025

0

Dr. Magoola, Dei BioPharma, secures US patents for universal mRNA cancer vaccine & affordable scFv immune therapy. Global treatment equity, ...

Dr. Matthias Magoola a Ugandan scientist, has filed more than 100 patents with the United States Patent and Trademark Office (USPTO) and is well published in several peer-reviewed scientific journals

BIG STORY! Dei Biophama to produce affordable, newly approved HIV drug in Uganda

by JOSEPH NSIMBI | UG STANDARD REPORTER

24/06/2025

0

The Dei BioPharma drugs and vaccines manufacturing facility in Matugga, near Kampala-Uganda. KAMPALA, Uganda — Ugandan biotechnology firm has announced it ...

Tag: Dei BioPharma